248 related articles for article (PubMed ID: 25395260)
1. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
Chancharoenthana W; Townamchai N; Pongpirul K; Kittiskulnam P; Leelahavanichkul A; Avihingsanon Y; Suankratay C; Wattanatorn S; Kittikowit W; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Transplant; 2014 Dec; 14(12):2814-20. PubMed ID: 25395260
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
[TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
Sumethkul V; Ingsathit A; Jirasiritham S
Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
[TBL] [Abstract][Full Text] [Related]
4. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
[TBL] [Abstract][Full Text] [Related]
5. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
[TBL] [Abstract][Full Text] [Related]
7. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
8. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
Yilmaz VT; Aliosmanoglu I; Erbis H; Ulger BV; Cetinkaya R; Suleymanlar G; Kocak H
Transpl Infect Dis; 2016 Feb; 18(1):55-62. PubMed ID: 26565663
[TBL] [Abstract][Full Text] [Related]
9. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
10. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
[TBL] [Abstract][Full Text] [Related]
11. Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: a prospective nonrandomized controlled study from a single center.
Jiang H; Wu J; Zhang X; Wu D; Huang H; He Q; Wang R; Wang Y; Zhang J; Chen J
Am J Transplant; 2009 Aug; 9(8):1853-8. PubMed ID: 19538486
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
13. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
14. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
[TBL] [Abstract][Full Text] [Related]
15. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
[TBL] [Abstract][Full Text] [Related]
16. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
[TBL] [Abstract][Full Text] [Related]
18. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
[TBL] [Abstract][Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
Wu Y; Chen Y; Zhu P; Ye B; Lu Y; Shi J; Tan Y; Zhao Y; Yu J; Lai X; Lan J; Si T; Ni L; Huang H; Luo Y
Ann Hematol; 2022 Mar; 101(3):631-641. PubMed ID: 34981143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
